D-dimer: old dogmas, new (COVID-19) tricks
D-dimer is a fibrin degradation product encompassing multiple cross-linked D domains
and/or E domains present in the original fibrinogen molecule, whose generation is only …
and/or E domains present in the original fibrinogen molecule, whose generation is only …
[HTML][HTML] The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
M Xiang, X Wu, H Jing, VA Novakovic… - Frontiers in …, 2023 - frontiersin.org
The role of hypoxia, vascular endothelial injury, and thrombotic inflammation in worsening
COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays …
COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays …
Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization
Background: Patients hospitalized with COVID-19 have an increased incidence of
thromboembolism. The role of extended thromboprophylaxis after hospital discharge is …
thromboembolism. The role of extended thromboprophylaxis after hospital discharge is …
Thrombotic Complications in Children with COVID-19 and MIS-C
R Kumar, MJ Rivkin, L Raffini - Journal of Thrombosis and Haemostasis, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) associated coagulopathy is multifactorial
and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet …
and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet …
It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19
JV Harte, C Coleman-Vaughan… - Critical Reviews in …, 2023 - Taylor & Francis
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led
to an unprecedented global healthcare crisis. While SARS-CoV-2-associated COVID-19 …
to an unprecedented global healthcare crisis. While SARS-CoV-2-associated COVID-19 …
[HTML][HTML] Need for a standardized translational drug development platform: Lessons learned from the repurposing of drugs for COVID-19
F Assmus, JS Driouich, R Abdelnabi, L Vangeel… - Microorganisms, 2022 - mdpi.com
In the absence of drugs to treat or prevent COVID-19, drug repurposing can be a valuable
strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on …
strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on …
COVID-19: hypercoagulability
A Cuker, F Peyvandi - uptodate [Internet]. Available from: https://www …, 2021 - uptodate.com
COVID-19: Hypercoagulability - UpToDate wolters kluwer English Why UpToDate? Product
Editorial Subscription Options Subscribe Sign in Learn how UpToDate can help you. Select the …
Editorial Subscription Options Subscribe Sign in Learn how UpToDate can help you. Select the …
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Thrombotic complications from COVID-19 are now well known and contribute to significant
morbidity and mortality. Different variants confer varying risks of thrombotic complications …
morbidity and mortality. Different variants confer varying risks of thrombotic complications …
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a
betacoronavirus responsible for the COVID-19 pandemic, causing respiratory disorders, and …
betacoronavirus responsible for the COVID-19 pandemic, causing respiratory disorders, and …
To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients
AC Spyropoulos - Hematology, 2022 - ashpublications.org
The field of thromboprophylaxis for acutely ill medical patients, including those hospitalized
for COVID-19, is rapidly evolving both in the inpatient setting and the immediate post …
for COVID-19, is rapidly evolving both in the inpatient setting and the immediate post …